Colon Cancer | NSABP CO6
A clinical trial comparing 5-Fluoroucil (5-FU) plus leucovorin (LV) and UFT plus LV for the treatment of patients with stages II and III carcinoma of the colon.
Schema
Summary
Adjuvant chemotherapy with 5-FU and LV given after surgery improves recurrence and cure rates for people with early colon cancer. Most chemotherapy is given through a tube into the vein (intra-venous infusion). UFT is a new chemotherapy drug that is given as a tablet; its effects on the cancer are similar to 5-FU. This study will determine if using UFT instead of 5-FU will result in people living as long and with better quality of life.
